lercanidipine, calcium channel blocker of the third generation: new possibilities in the treatment of arterial hypertension
Clicks: 138
ID: 246918
2015
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
0.3
/100
1 views
1 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Classification, modes of action and clinical effects of calcium channel blockers are presented. Advantages of the third generation of dihydropyridine calcium channel blockers are considered. Clinical pharmacology, studies on the efficacy, safety and prevention of hypertensive complications with lercanidipine are detailed.
| Reference Key |
ostroumova2015racionalnalercanidipine,
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;O. D. Ostroumova;M. L. Maksimov;I. I. Kopchenov |
| Journal | environmental technology |
| Year | 2015 |
| DOI | 10.1234/1819-6446-2013-1-79-85 |
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.